CDEK
← All organizations

Halozyme Therapeutics

For profitContributed to NMEWebsite ↗

Also known as: Halozyme and BiolineRx Ltd | HALOZYME THERAP | Halozyme Therapeutics | Halozyme Therapeutics, Inc.

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Nov 1, 2005

First marketed drug

Dec 2, 2005

First NDA

Dec 2, 2005

Last known activity

Jan 31, 2025

Timeline

1990s

  1. Jun 1, 1998

    Halozyme Therapeutics— Founded

2000s

  1. Dec 2, 2005

    hyaluronidase (human recombinant)— NDA Organization

  2. Dec 2, 2005

    hyaluronidase (human recombinant)— NDA Secondary Org

2020s

  1. Apr 14, 2022

    Antares Pharma Inc.— Acquired

Drugs by trial phase (33 distinct, 58 trials)

Phase 3 (2 own, 1 via acquisition)

Indications

Studied for

Marketed drugs (2)

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Recent trials (50)

Details

Founded
San Diego, CA, US Jun 1, 1998
First NDA
Dec 2, 2005
Last known activity
Jan 31, 2025